Presentation

Endoceuticsä is a private pharmaceutical company operating in the field of women’s health and hormone-sensitive cancer prevention and treatment. Following approval by the FDA of Intrarosaä in November 2016, for the treatment of dyspareunia, a symptom of vulvovaginal atrophy due to menopause, Endoceuticsä focuses on developing non estrogen-based therapies for sexual dysfunction and the other symptoms of menopause, including hot flushes, osteoporosis, muscle loss and type 2 diabetes. Hormonal therapies for breast, uterine and prostate cancer, male hypogonadism as well as endometriosis are also under development. Endoceuticsä has five Phase III product candidates addressing large market opportunities and two Phase I/II product candidates. Endoceuticsä has exclusive worldwide rights to patents, patent applications, technology and know-how related to all its products.

Job Offers

Spontaneous job application

No job offer found.

Locations

MSH
597 Sir Wilfrid Laurier Blvd
Mont-Saint-Hilaire (Québec) J3H 6C4
Laboratoire
1405 boul. du Parc Technologique, Suite 250
Québec (Québec) G1P 4P5
Complan
2795 boul Laurier, suite 500
Québec (Québec) G1V 4M7